| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.56B | 1.53B | 1.32B | 1.00B | 764.04M | 929.98M |
| Gross Profit | 723.36M | 591.13M | 597.97M | 475.36M | 308.35M | 659.27M |
| EBITDA | 133.19M | 148.36M | 89.48M | 39.34M | -321.49M | 203.48M |
| Net Income | 61.67M | 47.58M | -34.13M | -58.54M | -297.50M | 124.86M |
Balance Sheet | ||||||
| Total Assets | 1.21B | 1.25B | 1.19B | 1.22B | 1.29B | 1.42B |
| Cash, Cash Equivalents and Short-Term Investments | 10.74M | 32.40M | 42.69M | 83.16M | 141.00M | 286.45M |
| Total Debt | 422.85M | 415.91M | 713.92M | 731.80M | 745.06M | 505.30M |
| Total Liabilities | 660.05M | 673.84M | 877.11M | 872.28M | 898.95M | 756.82M |
| Stockholders Equity | 546.93M | 575.52M | 316.80M | 346.97M | 391.11M | 667.04M |
Cash Flow | ||||||
| Free Cash Flow | -24.39M | -13.86M | 3.57M | -28.50M | -372.96M | -138.43M |
| Operating Cash Flow | -16.68M | -11.67M | 15.24M | -19.38M | -338.31M | -115.44M |
| Investing Cash Flow | -12.72M | -11.31M | -14.85M | -9.13M | -42.58M | -64.02M |
| Financing Cash Flow | 34.66M | 17.36M | -40.86M | -29.34M | 235.43M | 97.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | $115.98M | 101.62 | 5.88% | ― | 16.79% | ― | |
54 Neutral | $271.00M | -51.51 | 15.11% | ― | 13.16% | ― | |
46 Neutral | $22.80M | 9.07 | 4.56% | ― | 19.30% | -17.56% | |
44 Neutral | $36.53M | -0.14 | -142.05% | ― | 7.56% | -344.04% | |
44 Neutral | $5.12M | -0.22 | -146.43% | ― | -6.84% | 97.23% | |
43 Neutral | $13.58M | -0.12 | -11.18% | ― | 624.24% | 85.46% |
On January 8, 2026, SelectQuote entered into a new $415 million senior secured credit facility consisting of a $325 million term loan led by Pathlight Capital and a $90 million revolving credit facility with UMB Bank, using roughly $313.8 million of the term loan proceeds to fully repay its prior debt and cover transaction costs. Announced publicly on January 12, 2026, the financing significantly extends the company’s debt maturity to January 2031, modestly lowers its cost of capital, increases peak-season revolver capacity from $72 million to $90 million, and reduces principal amortization requirements, collectively strengthening liquidity and operational flexibility as the company looks to leverage its roughly $1 billion in commissions receivable and the growing cash generation of its SelectRx and healthcare services operations, while its obligations remain secured by substantially all company and guarantor subsidiary assets and subject to customary covenants, coverage ratios, and borrowing-base tests tied to receivables.
The most recent analyst rating on (SLQT) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.
On November 11, 2025, SelectQuote, Inc. held its 2025 Annual Meeting of Stockholders, where 114,443,928 shares were represented. During the meeting, two Class III directors were elected, Deloitte & Touche LLP was ratified as the independent accounting firm for the fiscal year ending June 30, 2026, and the compensation for the company’s named executive officers was approved.
The most recent analyst rating on (SLQT) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.